While our results on IL-18 are suggestive of a TOXO-induced systemic inflammasome activation in both patients and HC, the latent infection could have an additive impact on the already increased IL-18 levels of patients with SMI13 which may result in more detrimental consequences in these patients relative to HC. The gene discussed is IL18; the disease is disease arising from reactivation of latent virus.